Related Experiment Video
Updated: Oct 31, 2025
07:37
A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure
Published on: July 14, 2016
15.4K
Forskolin eye drops improve retinal damage from ischemia/reperfusion
Li Liu1, Youde Jiang1, Jena J Steinle1
1Department of Ophthalmology, Visual, and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI.
Molecular Vision
|June 30, 2021
Summary
Forskolin eye drops protected against ischemia/reperfusion (I/R) injury by reducing neuronal and vascular damage. This protein kinase A (PKA) agonist offers a promising new therapeutic for local delivery to the eye.
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Background:
- Ischemia/reperfusion (I/R) injury can cause significant neuronal and vascular damage in the eye.
- Current therapeutic strategies for ocular I/R injury are limited.
Purpose of the Study:
- To investigate the neuroprotective and vasculoprotective effects of forskolin eye drops following ocular I/R.
- To determine if forskolin modulates protein kinase A (PKA) levels and inflammatory mediators.
Main Methods:
- C57BL/6J mice were subjected to an ocular I/R protocol.
- Forskolin (10 μM) eye drops were administered daily.
- Neuronal damage was assessed at 2 days and vascular damage at 10 days post-I/R; Western blotting analyzed PKA and inflammatory mediator levels.
Main Results:
- Forskolin eye drops significantly reduced neuronal and vascular damage compared to I/R alone.
- Forskolin treatment increased protein kinase A (PKA) levels.
- Levels of inflammatory mediators, including tumor necrosis factor alpha (TNF-α) and interleukin-1-β (IL-1β), were significantly decreased.
Conclusions:
- Forskolin eye drops demonstrate protective effects against I/R-induced ocular damage.
- These findings suggest forskolin as a potential therapeutic agent for local delivery in treating I/R injury.
